Related references
Note: Only part of the references are listed.Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Devaraj Ezhilarasan
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study
Maxime Tremblay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis
Atef Al Attar et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Cell and Tissue Therapy for the Treatment of Chronic Liver Disease
Yaron Bram et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 23, 2021 (2021)
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis
Yang An et al.
FRONTIERS IN MEDICINE (2021)
Galectin-3 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma
Mei Li et al.
MOLECULAR MEDICINE REPORTS (2021)
Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/ phase separation
Zihan Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
N-terminal tail prolines of Gal-3 mediate its oligomerization/phase separation COMMENT
Dharma Pally et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
Vinka Rupcic Rubin et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Naga Chalasani et al.
GASTROENTEROLOGY (2020)
Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
Atsuhiro Nagasaki et al.
SCIENTIFIC REPORTS (2020)
Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver
Lisa Rein-Fischboeck et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Hepatic fibrosis: A convergent response to liver injury that is reversible
Shuang Wang et al.
JOURNAL OF HEPATOLOGY (2020)
Galectin-3 modulates epithelial cell adaptation to stress at the ER-mitochondria interface
Lucie Coppin et al.
CELL DEATH & DISEASE (2020)
Prognostic role of galectins expression in patients with hepatic cancer A meta-analysis
Qi Shao et al.
MEDICINE (2020)
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
Gantumur Dolgormaa et al.
BRITISH JOURNAL OF CANCER (2020)
Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development
Aleksandar Arsenijevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
Mengjia Song et al.
BRITISH JOURNAL OF CANCER (2020)
MicroRNA interplay between hepatic stellate cell quiescence and activation
Devaraj Ezhilarasan
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Mapping glycan-mediated galectin-3 interactions by live cell proximity labeling
Eugene Joeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Galectins in Intra- and Extracellular Vesicles
Sebastian Baenfer et al.
BIOMOLECULES (2020)
ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study
Brianna Cyr et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection
Bojana Stojanovic et al.
FRONTIERS IN MICROBIOLOGY (2019)
Galectin-3 is associated with glomerular filtration rate and outcome in patients with stable decompensated cirrhosis
Theodora Oikonomou et al.
DIGESTIVE AND LIVER DISEASE (2019)
The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
Felipe Leite de Oliveira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
Aleksandar Arsenijevic et al.
FRONTIERS IN IMMUNOLOGY (2019)
Selective effects of ginseng pectins on galectin-3-mediated T cell activation and apoptosis
Huiting Xue et al.
CARBOHYDRATE POLYMERS (2019)
A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
Josephine Skat-Rordam et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1
Zilong Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
Maria Nicoline Baandrup Kristiansen et al.
BMC GASTROENTEROLOGY (2019)
The Structural Biology of Galectin-Ligand Recognition: Current Advances in Modeling Tools, Protein Engineering, and Inhibitor Design
Carlos P. Modenutti et al.
FRONTIERS IN CHEMISTRY (2019)
Effects of linker and liposome anchoring on lactose-functionalized glycomacromolecules as multivalent ligands for binding galectin-3
Tanja Freichel et al.
RSC ADVANCES (2019)
Geographic Variability in Liver Disease-Related Mortality Rates in the United States
Archita P. Desai et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease
Hong Cai et al.
CLINICAL BIOCHEMISTRY (2018)
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Devaraj Ezhilarasan et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions
Yi-Chen Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis
Ken Shirabe et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell function
Martina Sundqvist et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
The Role of Galectins as Modulators of Metabolism and Inflammation
Monica Fengsrud Brinchmann et al.
MEDIATORS OF INFLAMMATION (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Unconventional secretion of annexins and galectins
Stephanie J. Popa et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
Kirstine S. Tolbol et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model
Yan-Lan Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
Hee-Won Moon et al.
ANNALS OF LABORATORY MEDICINE (2018)
Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective
Devaraj Ezhilarasan
ARAB JOURNAL OF GASTROENTEROLOGY (2018)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition
Zi Cao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The intrinsically disordered N-terminal domain of galectin-3 dynamically mediates multisite self-association of the protein through fuzzy interactions
Yu-Hao Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Hepatic stellate cells secreting WFA+-M2BP: Its role in biological interactions with Kupffer cells
Yuki Bekki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
Laura Diaz-Alvarez et al.
MEDIATORS OF INFLAMMATION (2017)
The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells
Huiting Xue et al.
ONCOTARGET (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis
Felipe Leite de Oliveira et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis
Tianhua Liu et al.
SCIENTIFIC REPORTS (2017)
Glycosylation-dependent galectin-1/ neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells
Ming-Heng Wu et al.
SCIENTIFIC REPORTS (2017)
Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy
Yang Zhao et al.
CANCER RESEARCH (2017)
Hypermethylation of the galectin-3 promoter is associated with poor prognosis of acute-on-chronic hepatitis B liver failure
Jing Zhao et al.
DIGESTIVE AND LIVER DISEASE (2017)
Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
Marco Poeta et al.
CHILDREN-BASEL (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Liver Fibrosis: From Pathogenesis to Novel Therapies
Ralf Weiskirchen et al.
DIGESTIVE DISEASES (2016)
Galectin-3 regulates inflammasome activation in cholestatic liver injury
Jijing Tian et al.
FASEB JOURNAL (2016)
Oncogenic Driver Genes and the Inflammatory Microenvironment Dictate Liver Tumor Phenotype
Matthias S. Matter et al.
HEPATOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
Nada Pejnovic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens
Aleksandar Arsenijevic et al.
SCIENTIFIC REPORTS (2016)
Galectin-3 Activates PPARγ and Supports White Adipose Tissue Formation and High-Fat Diet-Induced Obesity
Jung-Hwan Baek et al.
ENDOCRINOLOGY (2015)
Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation
Nobuko Serizawa et al.
LABORATORY INVESTIGATION (2015)
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
Ilija Jeftic et al.
MOLECULAR MEDICINE (2015)
Serum Galectin-3 Levels in Children with Chronic Hepatitis B Infection and Inactive Hepatitis B Carriers
Ali Güneş
MEDICAL SCIENCE MONITOR (2015)
Prognostic Significance of Serum Galectin-3 Levels in Patients with Hepatocellular Cancer and Chronic Viral Hepatitis
Mehmet Ulu et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2015)
Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury
Vladislav Volarevic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma
Nada H. Eisa et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Shan-Shan Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells
Datong Zheng et al.
ONCOLOGY REPORTS (2014)
Nuclear transport of galectin-3 and its therapeutic implications
Tatsuyoshi Funasaka et al.
SEMINARS IN CANCER BIOLOGY (2014)
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Liu-cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Peter G. Traber et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
pH-Dependent Recycling of Galectin-3 at the Apical Membrane of Epithelial Cells
Tamara Straube et al.
TRAFFIC (2013)
Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
Joy X. Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Kouichi Miura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice
Vladislav Volarevic et al.
HEPATOLOGY (2012)
Nonalcoholic Fatty Liver Disease Multimodal Treatment Options for a Pathogenetically Multiple-hit Disease
Stergios A. Polyzos et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Alteration of protein glycosylation in human hepatic stellate cells activated with transforming growth factor-β1
Yannan Qin et al.
JOURNAL OF PROTEOMICS (2012)
Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease
Kazuhiro Nomoto et al.
SCIENTIFIC WORLD JOURNAL (2012)
Role of Galectin-3 in Acetaminophen-Induced Hepatotoxicity and Inflammatory Mediator Production
Ana-Cristina Dragomir et al.
TOXICOLOGICAL SCIENCES (2012)
Serum galectin-3 levels in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
CLINICAL BIOCHEMISTRY (2011)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function
Josef Wanninger et al.
CYTOKINE (2011)
Elevation of Serum Galectin-3 and Liver Stiffness Measured by Transient Elastography in Biliary Atresia
S. Honsawek et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2011)
Matrilysin-1 (MMP7) Cleaves Galectin-3 and Inhibits Wound Healing in Intestinal Epithelial Cells
Manjula Puthenedam et al.
INFLAMMATORY BOWEL DISEASES (2011)
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Carla Iacobini et al.
JOURNAL OF HEPATOLOGY (2011)
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
Pratima Nangia-Makker et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Regulation of Prostate Cancer Progression by Galectin-3
Yi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The immunological potential of galectin-1 and-3
Amy Dhirapong et al.
AUTOIMMUNITY REVIEWS (2009)
The α-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
Michelle C. Miller et al.
GLYCOBIOLOGY (2009)
Galectins in innate immunity: dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs)
Sachiko Sato et al.
IMMUNOLOGICAL REVIEWS (2009)
The regulation of inflammation by galectin-3
Neil C. Henderson et al.
IMMUNOLOGICAL REVIEWS (2009)
Endogenous Galectin-3 Is Localized in Membrane Lipid Rafts and Regulates Migration of Dendritic Cells
Daniel K. Hsu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals Its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry
Alexandra A. Mourad-Zeidan et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
Neil C. Henderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Galectins: structure, function and therapeutic potential
Ri-Yao Yang et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Macrophage activation and polarization
Fernando Oneissi Martinez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Galectin-3 cleavage: A novel surrogate marker for matrix metalloproteinase activity in growing breast cancers
Pratima Nangia-Makker et al.
CANCER RESEARCH (2007)
Galectins in the tumor endothelium: opportunities for combined cancer therapy
Victor L. J. L. Thijssen et al.
BLOOD (2007)
Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease
M. Butscheid et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice
K. Nomoto et al.
JOURNAL OF PATHOLOGY (2006)
Transport of galectin-3 between the nucleus and cytoplasm. II. Identification of the signal for nuclear export
Su-Yin Li et al.
GLYCOBIOLOGY (2006)
Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import
Peter J. Davidson et al.
GLYCOBIOLOGY (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer
T Fukumori et al.
CANCER RESEARCH (2006)
Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer
P Lukyanov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes
N Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Quaternary solution structures of galectins-1,-3, and-7
S Morris et al.
GLYCOBIOLOGY (2004)
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs
Y Takenaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Shuttling of galectin-3 between the nucleus and cytoplasm
PJ Davidson et al.
GLYCOBIOLOGY (2002)
Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia
S Sato et al.
JOURNAL OF IMMUNOLOGY (2002)
Galectin-3 and metastasis
Y Takenaka et al.
GLYCOCONJUGATE JOURNAL (2002)
Galectin-3 expression and subcellular localization in senescent human fibroblasts
KP Openo et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
